Hospital revisits 20-Year-Old antibiotic plan for sick babies
NCT ID NCT07460349
Summary
This study aims to verify if the current gentamicin dosing schedule used for newborns (up to 7 days old) with a serious blood infection (sepsis) is still safe and effective. Researchers will measure antibiotic levels in the babies' blood and check for any signs of kidney or hearing problems, which are rare side effects. The goal is to confirm the hospital's dosing is optimal by comparing new results to old, unpublished data, potentially creating a standard guideline for the region.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-ONSET SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital: London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.